Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 601 to 625 of 921

Sort by

Guidance programme: Technology appraisal guidance`Remove $Guidance programme: Technology appraisal guidance filter`

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ocrelizumab for treating relapsing–remitting multiple sclerosis	TA533	25 July 2018	25 July 2018
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer	TA531	18 July 2018	18 July 2018
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy	TA530	4 July 2018	4 July 2018
Beta interferons and glatiramer acetate for treating multiple sclerosis	TA527	27 June 2018	27 June 2018
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	TA217	23 March 2011	20 June 2018
Guselkumab for treating moderate to severe plaque psoriasis	TA521	13 June 2018	13 June 2018
Midostaurin for untreated acute myeloid leukaemia	TA523	13 June 2018	13 June 2018
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma	TA524	13 June 2018	13 June 2018
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy	TA525	13 June 2018	13 June 2018
Arsenic trioxide for treating acute promyelocytic leukaemia	TA526	13 June 2018	13 June 2018
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy	TA520	16 May 2018	16 May 2018
Tocilizumab for treating giant cell arteritis	TA518	18 April 2018	18 April 2018
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen	TA515	28 March 2018	28 March 2018
Cabozantinib for treating medullary thyroid cancer	TA516	28 March 2018	28 March 2018
Brodalumab for treating moderate to severe plaque psoriasis	TA511	21 March 2018	21 March 2018
Tivozanib for treating advanced renal cell carcinoma	TA512	21 March 2018	21 March 2018
Obinutuzumab for untreated advanced follicular lymphoma	TA513	21 March 2018	21 March 2018
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee	TA508	7 March 2018	7 March 2018
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer	TA509	7 March 2018	7 March 2018
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C	TA507	21 February 2018	21 February 2018
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women	TA160	27 October 2008	7 February 2018
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women	TA161	27 October 2008	7 February 2018
Pirfenidone for treating idiopathic pulmonary fibrosis	TA504	6 February 2018	6 February 2018
Intrabeam radiotherapy system for adjuvant treatment of early breast cancer	TA501	31 January 2018	31 January 2018
Ibrutinib for treating relapsed or refractory mantle cell lymphoma	TA502	31 January 2018	31 January 2018

Results per page

10
25
50
All